AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
AGONIST ACTIVITY OF ANTIESTROGEN-RECEPTOR COMPLEXES TO REGULATE UROKINASE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I (PAI-1) ENDOGENOUS GENE-EXPRESSION IN BREAST-CANCER CELLS
Authors: LEVENSON AS SVOBODA KM KWAAN HC JORDAN VC
Citation: As. Levenson et al., AGONIST ACTIVITY OF ANTIESTROGEN-RECEPTOR COMPLEXES TO REGULATE UROKINASE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I (PAI-1) ENDOGENOUS GENE-EXPRESSION IN BREAST-CANCER CELLS, Cancer letters, 125(1-2), 1998, pp. 215-220
THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER STENTING AND TICLOPIDINE
Authors: BENNETT CL KISS JE WEINBERG PD PINEVICH AJ GREEN D KWAAN HC FELDMAN MD
Citation: Cl. Bennett et al., THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER STENTING AND TICLOPIDINE, Lancet, 352(9133), 1998, pp. 1036-1037
ESTRADIOL REGULATION OF THE COMPONENTS OF THE PLASMINOGEN-PLASMIN SYSTEM IN MDA-MB-231 HUMAN BREAST-CANCER CELLS STABLY EXPRESSING THE ESTROGEN-RECEPTOR
Authors: LEVENSON AS KWAAN HC SVOBODA KM WEISS IM SAKURAI S JORDAN VC
Citation: As. Levenson et al., ESTRADIOL REGULATION OF THE COMPONENTS OF THE PLASMINOGEN-PLASMIN SYSTEM IN MDA-MB-231 HUMAN BREAST-CANCER CELLS STABLY EXPRESSING THE ESTROGEN-RECEPTOR, British Journal of Cancer, 78(1), 1998, pp. 88-95
THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH TICLOPIDINE - A REVIEW OF 60 CASES
Authors: BENNETT CL WEINBERG PD ROZENBERGBENDROR K YARNOLD PR KWAAN HC GREEN D
Citation: Cl. Bennett et al., THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH TICLOPIDINE - A REVIEW OF 60 CASES, Annals of internal medicine, 128(7), 1998, pp. 541-544
INCIDENCE OF THROMBOTIC THROMBOCYTOPENIC PURPURA FOLLOWING CORONARY STENT PLACEMENT AND TICLOPIDINE THERAPY
Authors: FELDMAN MD KISS JE WEINBERG PD PINEVICH AJ GREEN D KWAAN HC BENNETT CL
Citation: Md. Feldman et al., INCIDENCE OF THROMBOTIC THROMBOCYTOPENIC PURPURA FOLLOWING CORONARY STENT PLACEMENT AND TICLOPIDINE THERAPY, The American journal of cardiology, 82, 1998, pp. 19-19
THROMBIN STIMULATES EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN DU-145 PROSTATE-CANCER CELLS
Authors: YOSHIDA E VERRUSIO EN MIHARA H OH DY KWAAN HC
Citation: E. Yoshida et al., THROMBIN STIMULATES EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN DU-145 PROSTATE-CANCER CELLS, Fibrinolysis & proteolysis, 11(3), 1997, pp. 147-154
DIGITAL ISCHEMIA AND GANGRENE DUE TO RED-BLOOD-CELL AGGREGATION INDUCED BY ACQUIRED DYSFIBRINOGENEMIA
Authors: KWAAN HC LEVIN M SAKURAI S KUCUK O ROONEY MW LIS LJ KAUFFMAN JW
Citation: Hc. Kwaan et al., DIGITAL ISCHEMIA AND GANGRENE DUE TO RED-BLOOD-CELL AGGREGATION INDUCED BY ACQUIRED DYSFIBRINOGENEMIA, Journal of vascular surgery, 26(6), 1997, pp. 1061-1068
ELEVATIONS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND DIFFERENTIAL EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN DISEASED AORTA
Authors: SHIREMAN PK MCCARTHY WJ PEARCE WH SHIVELY VP CIPOLLONE M KWAAN HC
Citation: Pk. Shireman et al., ELEVATIONS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND DIFFERENTIAL EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN DISEASED AORTA, Journal of vascular surgery, 25(1), 1997, pp. 157-164
THE DEVELOPMENT AND DEGRADATION OF FIBRIN NETWORKS FROM THE NORMAL AND X-RAY-IRRADIATED FIBRINOGENS ANALYZED BY A CONFOCAL LASER-SCANNING MICROSCOPY (CLSM)
Authors: TAKAHASHI K KOH CS YAMAGISHI T KWAAN HC
Citation: K. Takahashi et al., THE DEVELOPMENT AND DEGRADATION OF FIBRIN NETWORKS FROM THE NORMAL AND X-RAY-IRRADIATED FIBRINOGENS ANALYZED BY A CONFOCAL LASER-SCANNING MICROSCOPY (CLSM), Thrombosis and haemostasis, 1997, pp. 143-143
CHANGE IN THE ENZYMATIC-PROPERTIES OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) IN THE PRESENCE OF NONIONIC RADIOGRAPHIC CONTRAST AGENT (CA)
Authors: YAMAGISHI T TAKAHASHI K AKITA M KWAAN HC ARAI M FUKUTAKE K
Citation: T. Yamagishi et al., CHANGE IN THE ENZYMATIC-PROPERTIES OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) IN THE PRESENCE OF NONIONIC RADIOGRAPHIC CONTRAST AGENT (CA), Thrombosis and haemostasis, 1997, pp. 2042-2042
THROMBOTIC THROMBOCYTOPENIC PURPURA AND THE HEMOLYTIC-UREMIC SYNDROME- INTRODUCTION
Authors: KWAAN HC GANGULY P
Citation: Hc. Kwaan et P. Ganguly, THROMBOTIC THROMBOCYTOPENIC PURPURA AND THE HEMOLYTIC-UREMIC SYNDROME- INTRODUCTION, Seminars in hematology, 34(2), 1997, pp. 81-82
CANCER-ASSOCIATED AND DRUG-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME
Authors: GORDON LI KWAAN HC
Citation: Li. Gordon et Hc. Kwaan, CANCER-ASSOCIATED AND DRUG-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME, Seminars in hematology, 34(2), 1997, pp. 140-147
MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME
Authors: KWAAN HC SOFF GA
Citation: Hc. Kwaan et Ga. Soff, MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEMOLYTIC-UREMIC SYNDROME, Seminars in hematology, 34(2), 1997, pp. 159-166
THE MECHANISM OF CANCER-MEDIATED CONVERSION OF PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR ANGIOSTATIN
Authors: GATELY S TWARDOWSKI P STACK MS CUNDIFF DL GRELLA D CASTELLINO FJ ENGHILD J KWAAN HC LEE F KRAMER RA VOLPERT O BOUCK N SOFF GA
Citation: S. Gately et al., THE MECHANISM OF CANCER-MEDIATED CONVERSION OF PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR ANGIOSTATIN, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10868-10872
TICLOPIDINE ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) - AGE AND TREATMENT ASSOCIATED MORTALITY
Authors: WEINBERG PD BENNETT CL ROZENBERGBENDROR K KWAAN HC GREEN D
Citation: Pd. Weinberg et al., TICLOPIDINE ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) - AGE AND TREATMENT ASSOCIATED MORTALITY, Blood, 90(10), 1997, pp. 2053-2053
A NOVEL ACQUIRED DYSFIBRINOGENEMIA PRODUCING RED-CELL AGGREGATION ANDDIGITAL ISCHEMIA
Authors: KWAAN HC TAKAHASHI K SAKURAI S LEVIN M KUCUK O ROONEY MW LIS LJ KAUFMAN JW
Citation: Hc. Kwaan et al., A NOVEL ACQUIRED DYSFIBRINOGENEMIA PRODUCING RED-CELL AGGREGATION ANDDIGITAL ISCHEMIA, Blood, 90(10), 1997, pp. 2088-2088
PLASMINOGEN-ACTIVATOR LEVELS ARE INFLUENCED BY LOCATION AND VARICOSITY IN GREATER SAPHENOUS-VEIN
Authors: SHIREMAN PK MCCARTHY WJ PEARCE WH SHIVELY VP CIPOLLONE M KWAAN HC YAO JST
Citation: Pk. Shireman et al., PLASMINOGEN-ACTIVATOR LEVELS ARE INFLUENCED BY LOCATION AND VARICOSITY IN GREATER SAPHENOUS-VEIN, Journal of vascular surgery, 24(5), 1996, pp. 719-724
ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ATHEROSCLEROTIC AORTA
Authors: SHIREMAN PK MCCARTHY WJ PEARCE WH PATTERSON BK SHIVELY VP CIPOLLONE M TAMARINA N VERRUSIO EN KWAAN HC
Citation: Pk. Shireman et al., ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ATHEROSCLEROTIC AORTA, Journal of vascular surgery, 23(5), 1996, pp. 810-817
REGULATION OF THE SECRETION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN T98G HUMAN GLIOBLASTOMA CELLS BY CYTOKINES AND DEXAMETHASONE
Authors: YOSHIDA E OHMURA S KAWANO J SUGIKI M KWAAN HC MARUYAMA M
Citation: E. Yoshida et al., REGULATION OF THE SECRETION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN T98G HUMAN GLIOBLASTOMA CELLS BY CYTOKINES AND DEXAMETHASONE, Fibrinolysis, 10(5-6), 1996, pp. 303-307
HUMAN PROSTATE CARCINOMA-CELLS EXPRESS ENZYMATIC-ACTIVITY THAT CONVERTS HUMAN PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR, ANGIOSTATIN
Authors: GATELY S TWARDOWSKI P STACK MS PATRICK M BOGGIO L CUNDIFF DL SCHNAPER HW MADISON L VOLPERT O BOUCK N ENGHILD J KWAAN HC SOFF GA
Citation: S. Gately et al., HUMAN PROSTATE CARCINOMA-CELLS EXPRESS ENZYMATIC-ACTIVITY THAT CONVERTS HUMAN PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR, ANGIOSTATIN, Cancer research, 56(21), 1996, pp. 4887-4890
PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR EXPRESSION BY NORMAL AND ANEURYSMAL HUMAN AORTIC SMOOTH-MUSCLE CELLS IN CULTURE
Authors: LOUWRENS HD KWAAN HC PEARCE WH YAO JST VERRUSIO E
Citation: Hd. Louwrens et al., PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR EXPRESSION BY NORMAL AND ANEURYSMAL HUMAN AORTIC SMOOTH-MUSCLE CELLS IN CULTURE, European journal of vascular and endovascular surgery, 10(3), 1995, pp. 289-293
ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ATHEROSCLEROTIC AORTA
Authors: SHIERMAN PK MCCARTHY WJ PEARCE WH SHIVELY VP CIPOLLONE M VERRUSIO EN KWAAN HC
Citation: Pk. Shierman et al., ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ATHEROSCLEROTIC AORTA, Thrombosis and haemostasis, 73(6), 1995, pp. 1417-1417
EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY HUMAN PROSTATE CARCINOMA-CELLS INHIBITS PRIMARY TUMOR-GROWTH, TUMOR-ASSOCIATED ANGIOGENESIS, AND METASTASIS TO LUNG AND LIVER IN AN ATHYMIC MOUSE MODEL
Authors: SOFF GA SANDEROWITZ J GATELY S VERRUSIO E WEISS I BREM S KWAAN HC
Citation: Ga. Soff et al., EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY HUMAN PROSTATE CARCINOMA-CELLS INHIBITS PRIMARY TUMOR-GROWTH, TUMOR-ASSOCIATED ANGIOGENESIS, AND METASTASIS TO LUNG AND LIVER IN AN ATHYMIC MOUSE MODEL, The Journal of clinical investigation, 96(6), 1995, pp. 2593-2600
IDENTIFICATION AND CHARACTERIZATION OF PLASMINOGEN-ANGIOSTATIN CONVERTING-ENZYME FROM HUMAN PROSTATE CARCINOMA-CELLS
Authors: SOFF GA GATELY ST TWARDOWSKI PW STACK S KWAAN HC
Citation: Ga. Soff et al., IDENTIFICATION AND CHARACTERIZATION OF PLASMINOGEN-ANGIOSTATIN CONVERTING-ENZYME FROM HUMAN PROSTATE CARCINOMA-CELLS, Blood, 86(10), 1995, pp. 2957-2957
EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS INCREASED BY THROMBIN IN DU-145 PROSTATE-CANCER CELLS
Authors: YOSHIDA E KWAAN HC VERRUSIO EN
Citation: E. Yoshida et al., EXPRESSION OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS INCREASED BY THROMBIN IN DU-145 PROSTATE-CANCER CELLS, Blood, 86(10), 1995, pp. 2979-2979
Risultati: 1-25 | 26-40